Condition
Hearing Loss, High-Frequency
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06176625Not ApplicableCompleted
Sight and Hearing Investigation Into Effects on Delirium
NCT06161857RecruitingPrimary
High Frequency ABR
NCT01975571Not ApplicableCompletedPrimary
Hybrid Cochlear Implants in Severe to Profound Adults, Children, and Adolescents
NCT05343026Not ApplicableUnknown
Efficacy of Hearing-aid Treatment for Patients With Tinnitus and Co-existing Hearing Loss
Showing all 4 trials